Acasti Pharma (ACST)
(Delayed Data from NSDQ)
$3.18 USD
+0.02 (0.63%)
Updated Jun 12, 2024 12:03 PM ET
After-Market: $3.25 +0.07 (2.20%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Acasti Pharma, Inc. [ACST]
Reports for Purchase
Showing records 41 - 43 ( 43 total )
Company: Acasti Pharma, Inc.
Industry: Medical - Generic Drugs
Research Update:Positive results from two clinical trials give hope for future commercialization
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: Acasti Pharma, Inc.
Industry: Medical - Generic Drugs
New board members and clinical trial optimism highlight quarter
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D
Company: Acasti Pharma, Inc.
Industry: Unclassified
Initiation of Coverage: Acasti Pharma: Looking for the Thrill with Biotech Krill
Provider: STONEGATE CAPITAL MARKETS
Analyst: TRANG D